Patient With HIV-Associated Plasmablastic Lymphoma Responding to Bortezomib Alone and in Combination With Dexamethasone, Gemcitabine, Oxaliplatin, Cytarabine, and Pegfilgrastim Chemotherapy and Lenalidomide Alone-Reference-Cited by-同舟云学术

Patient With HIV-Associated Plasmablastic Lymphoma Responding to Bortezomib Alone and in Combination With Dexamethasone, Gemcitabine, Oxaliplatin, Cytarabine, and Pegfilgrastim Chemotherapy and Lenalidomide Alone

Published:2010-12-01 Issue:34 Volume:28 Page:e704-e708
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bibas Michele¹,Grisetti Susanna¹,Alba Lucia¹,Picchi Giovanna¹,Del Nonno Franca¹,Antinori Andrea¹

Affiliation:

1. National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.0038

Reference14 articles.

1. ES Jaffe, NL Harris, H Stein , etal: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 Lyon, France IARC Press

2. Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection

3. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

4. Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

5. Prognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic Lymphoma

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cephalic and ocular manifestations of EBV-associated plasmablastic lymphoma: Clinical and radiological response to bortezomib, EPOCH, and intrathecal methotrexate;Radiology Case Reports;2024-10

2. Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-05-20

3. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on therapy;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

4. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma;Blood;2024-01-11

5. Epidemiologic Characteristics, Treatment Patterns, and Survival Analysis of Plasmablastic Lymphoma in the United States: A SEER and NCDB Analysis;Clinical Lymphoma Myeloma and Leukemia;2023-12